News for Inovio Pharmaceuticals Inc (GBMB.BE)

Hagens Berman urges XL Fleet Corp. (NYSE: XL) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.

/PRNewswire/ -- Geneos Therapeutics, a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer,...

Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs Geneos expands its lead program for treatin...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ma...

Inovio said it was testing the impact of its vaccine candidate, IN0-4800, on new SARS-CoV-2 variants, as well as developing next-generation Covid-19 vaccine candidates that could be tailored to known and unknown SARS-CoV-2 variants

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into Inovio... | February 27, 2021

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23) ...

(RTTNews) - Inovio Pharmaceuticals Inc. (INO) and Qiagen N.V. (QGEN) announced Wednesday their collaboration to develop next generation sequencing...

/PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership...

Pune, India, Feb. 18, 2021 (GLOBE NEWSWIRE) -- The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% ...

Upgrades According to Citigroup, the prior rating for YETI Holdings Inc (NYSE:YETI) was changed from Neutral to Buy. In the fourth quarter, YETI Holdings ...

New York, USA, Feb. 10, 2021 (GLOBE NEWSWIRE) -- According to a newly published report by Research Dive, the global human papillomavirus vaccine market is ...

Today's Daily Dose brings you news about FDA approval of Adamas' GOCOVRI for an expanded indication, positive results from Arcutis' plaque psoriasis trial, Concert Pharma's disappointing data from schizophrenia trial, and the progress in Clover's phase I adjuvanted trial of COVID-19 S-Trimer vaccine candidates, to name a few.

Midway through trading Monday, the Dow traded up 0.73% to 30,202.28 while the NASDAQ rose 2.16% to 13,352.59. The S&P also rose, gaining 1.4% to ...

Robinhood added additional restrictions to trades on its platform late Friday. The restrictions include the ability to only buy one share of GameStop Corp ...